O. Klungel

First name

O.

Middle name

H.

Last name

Klungel

Abbing-Karahagopian, V., Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., et al. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.

View

Abbing-Karahagopian, V., Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., et al. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z

View

van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G., & van Staa, T. P. (2015). Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2015.08.033

View

Wing, K., Bhaskaran, K., Smeeth, L., van Staa, T. P., Klungel, O. H., Reynolds, R. F., & Douglas, I. (2016). Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury. BMJ Open. http://doi.org/10.1136/bmjopen-2016-012102

View

Requena, G., Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., et al. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816

View

Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825

View

Wing, K., Bhaskaran, K., Pealing, L., Root, A., Smeeth, L., van Staa, T. P., et al. (2017). Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkx183

View

De Jong, H. J. I., van Staa, T. P., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., et al. (2017). Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2016-210936

View

Ankarfeldt, M. Z., Thorsted, B. L., Groenwold, R. H., Adalsteinsson, E., Ali, M. S., & Klungel, O. H. (2017). Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s124054

View

van Dalem, J., Brouwers, M., Stehouwer, C. D. A., Krings, A., Klungel, O. H., Driessen, J. H. M., et al. (2018). Risk of a first-ever acute myocardial infarction and all-cause mortality with sulphonylurea treatment: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13168

View